ReviewNeurology(R) neuroimmunology & neuroinflammation2020

An argument for broad use of high efficacy treatments in early multiple sclerosis.

James M Stankiewicz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.